Preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS) are two procedures that can be used to screen for genetic abnormalities in embryos.
PGD involves testing for specific genetic conditions that are known to run in the family. PGS, on the other hand, is a screening test that looks for a wide range of genetic abnormalities.
These procedures can screen for various genetic conditions, including Down syndrome, cystic fibrosis, and sickle cell anaemia. PGD and PGS are typically performed before in vitro fertilization (IVF) and can help to ensure that only healthy embryos are implanted into the uterus. These techniques can be used to screen for a wide range of conditions, including chromosomal abnormalities, genetic disorders, and single-gene defects.
Biopsying day-5 blastocyst cells to identify chromosomal aneuploidies prior to transfer.
Complete 7-step PGD & PGS clinical protocol.
PGD testing is conducted during the normal IVF process once the eggs have been extracted and fertilized and cell division has begun.
When the embryos are 5 days old, a few cells are extracted using laser, and then the embryos are frozen safely.
As part of the procedure, the specialist will examine the DNA of each cell to determine if any abnormal genes are present in any of the embryos.
After the PGD has determined that the embryos are free of genetic disorders, they will be placed inside the uterus through IVF. The patient and doctor will then wait for the implantation to take place and for the pregnancy to be successful.
Additionally, if the other embryos do not contain any genetic disorders, they will be safely frozen and can be used later.
The embryos that have genetic disorders are destroyed.
The development process takes about 5 days, followed by testing that takes about 2 weeks. Your doctor will discuss the results afterwards.
Common questions about preimplantation genetic testing (PGD/PGS/PGT).
Preimplantation genetic testing is a laboratory procedure used during IVF to evaluate embryos for chromosomal and genetic abnormalities before transferring them to the uterus.
PGD evaluates embryo for single gene inherited disorder, PGS evaluates the embryo for abnormal number of chromosomes and PGT in the modern system that is done for structural chromosomal structures.
PGT-M is considered when parents have identified a clear risk of passing on inherited conditions and use IVF to select unaffected embryos before transferring them to the uterus.
PGT-A is a screening procedure performed during IVF to evaluate the chromosome number of developing embryos, and the limitations of this procedure involve no diagnostic guarantee, chromosomal mosaicism and the risk of false results.
No, genetic testing of embryos doesn’t guarantee a healthy pregnancy or baby because not all conditions are tested during genetic testing.
With the help of a procedure called trophectoderm biopsy, embryo cells are collected for preimplantation genetic testing.
The factors considered by couples before undergoing PGD or PGS testing in Delhi include assisted reproductive technology, realistic expectations, clinic accreditation and prohibition of sex selection.
No, not every genetic or chromosomal condition is identified by embryo genetic testing.
Genetic counselling is important before and after preimplantation genetic testing because it helps couples and individuals navigate emotional stress, medical decisions and technical limitations.
Non-therapeutic embryo genetic manipulation and non-medical sex selection are the ethical restrictions that apply to embryo genetic testing and sex selection in India.